Aoxing Pharmaceutical Company Inc
Aoxing Pharmaceutical Company, Inc. a specialty pharmaceutical company, engages in research and development, manufacture, and distribution of narcotic, pain-management, and addiction treatment pharmaceutical products primarily in the People's Republic of China. The company's principal products include Zhongtong'an, a capsule of herbal extraction for the indication of oral and dental pain; and Yiq… Read more
Market Cap & Net Worth: Aoxing Pharmaceutical Company Inc (AOXG)
Aoxing Pharmaceutical Company Inc (PINK:AOXG) has a market capitalization of $3.05 Million ($3.05 Million) as of March 18, 2026. Listed on the PINK stock exchange, this USA-based company holds position #38067 globally and #12397 in its home market, demonstrating a 23.08% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Aoxing Pharmaceutical Company Inc's stock price $0.01 by its total outstanding shares 381209195 (381.21 Million).
Aoxing Pharmaceutical Company Inc Market Cap History: 2015 to 2025
Aoxing Pharmaceutical Company Inc's market capitalization history from 2015 to 2025. Data shows change from $254.65 Million to $3.05 Million (-42.39% CAGR).
Aoxing Pharmaceutical Company Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Aoxing Pharmaceutical Company Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
3.77x
Aoxing Pharmaceutical Company Inc's market cap is 3.77 times its annual revenue
0.00x
Higher than industry averageLatest Price to Earnings (P/E) Ratio
59.19x
Aoxing Pharmaceutical Company Inc's market cap is 59.19 times its annual earnings
0.00x
Higher than industry averageWhat These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $254.65 Million | $25.48 Million | $5.50 Million | 9.99x | 46.34x |
| 2016 | $121.99 Million | $32.33 Million | $2.06 Million | 3.77x | 59.19x |
Competitor Companies of AOXG by Market Capitalization
Companies near Aoxing Pharmaceutical Company Inc in the global market cap rankings as of March 18, 2026.
Key companies related to Aoxing Pharmaceutical Company Inc by market ranking:
- CLUS (PINK:CLUS): Ranked #1968 globally with a market cap of $8.00 Billion USD.
- Cartesian Growth Corporation II Warrant (NASDAQ:RENEW): Ranked #8546 globally with a market cap of $736.93 Million USD.
- Nh Special Purpose Acquisition 14 Co. Ltd (KQ:319400): Ranked #8994 globally with a market cap of $660.01 Million USD ( ₩966.39 Billion KRW).
- EQV Ventures Acquisition Corp. II (NYSE:EVAC): Ranked #10613 globally with a market cap of $465.51 Million USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #1968 | CLUS | PINK:CLUS | $8.00 Billion | $200.00 |
| #8546 | Cartesian Growth Corporation II Warrant | NASDAQ:RENEW | $736.93 Million | $138.87 |
| #8994 | Nh Special Purpose Acquisition 14 Co. Ltd | KQ:319400 | $660.01 Million | ₩30450.00 |
| #10613 | EQV Ventures Acquisition Corp. II | NYSE:EVAC | $465.51 Million | $10.07 |
Aoxing Pharmaceutical Company Inc Historical Marketcap From 2015 to 2025
Between 2015 and today, Aoxing Pharmaceutical Company Inc's market cap moved from $254.65 Million to $ 3.05 Million, with a yearly change of -42.39%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $3.05 Million | -42.45% |
| 2024 | $5.30 Million | +348.39% |
| 2023 | $1.18 Million | +158.33% |
| 2022 | $457.45K | -60.00% |
| 2021 | $1.14 Million | -70.00% |
| 2020 | $3.81 Million | 0.00% |
| 2019 | $3.81 Million | 0.00% |
| 2018 | $3.81 Million | -75.00% |
| 2017 | $15.25 Million | -87.50% |
| 2016 | $121.99 Million | -52.10% |
| 2015 | $254.65 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Aoxing Pharmaceutical Company Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $3.05 Million USD |
| MoneyControl | $3.05 Million USD |
| MarketWatch | $3.05 Million USD |
| marketcap.company | $3.05 Million USD |
| Reuters | $3.05 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.